Eric Converse is the founder of PreciseDx. PreciseDx has raised $32M in total funding. Latest round: Series B. Based in New York, NY.
Eric Converse is the CEO of PreciseDx, a company specializing in AI-powered oncology diagnostics. He has experience in imaging diagnostics and AI/ML technologies. PreciseDx recently raised $11 million in funding led by Eventide Asset Management, Merck Global Health Innovation Fund, and Philips Ventures, and secured an additional $20.7 million in Series B funding, bringing its total funding to $31.5 million. The company's flagship product, PreciseBreast, is an AI-enabled diagnostic tool for breast cancer risk assessment.
Full founder directory · Investor directory · Company funding database · Fundraising library